ReviewDrug design, development and therapy2016

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy.

Paolo Grassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.